July 7, 2026
By: Stuart D. Anderson
In the high-stakes arena of healthcare M&A, the "closing" is only the beginning. As we navigate mid-2026, market data from the American Hospital Association (AHA) highlights that while deal value remains strong, reimbursement volatility and labor cost inflation are squeezing margins post-acquisition. For any strategic buyer, a robust cash contingency reserve is no longer optional: it is the gold standard for operational stability.
The Key Takeaway
A contingency reserve serves as your financial shock absorber against payer rate changes and staffing gaps. At White Coat Financial Partners, we empower buyers to maintain this liquidity without diluting equity or taking on restrictive debt by utilizing AR-Backed Working Capital.
The Financial Health of Post-Acquisition Transitions
Transitioning a medical practice often uncovers "hidden friction," from unexpected equipment repairs to sudden shifts in the Centers for Medicare & Medicaid Services (CMS) reimbursement schedules. Without a liquid buffer, these costs can derail your capital optimization strategy. For buyers, that means protecting post-close stability. For sellers, it means understanding why a buyer may insist on reserves even when the seller wants a faster, cleaner exit. We recommend a reserve that covers at least three months of fixed operating expenses to preserve strategic advantage during the integration phase.
Step 8: Obtain Necessary Approvals
Before closing, both sides need clarity on regulatory and operational approvals. Buyers should verify payer enrollment and credentialing timelines, review any required CMS change of ownership guidance, and confirm whether state or contract-level consents could delay cash flow. Sellers benefit when this work starts early because approval delays can create last-minute renegotiation pressure. A disciplined approval process protects continuity, preserves valuation, and reduces avoidable surprises.
Step 9: Close the Deal
This is where buyer and seller priorities often diverge. Sellers usually want minimal holdbacks because they are seeking a clean exit, faster access to proceeds, and less post-close entanglement. Buyers, however, need contingency reserves to absorb timing gaps tied to payer credentialing, staffing transitions, and reimbursement delays. The practical answer is balance: structure the deal so the seller achieves certainty while the buyer retains enough liquidity to manage real post-close risk.
Protecting Stability with AR-Backed Working Capital
Maintaining a massive cash pile can be inefficient. Our solution allows you to leverage the aggregate sum of your Accounts Receivable to create a dynamic reserve, helping bridge the gap between a seller's preference for limited holdbacks and a buyer's need for post-close flexibility. This non-notification lending model ensures:
- ✅ Full Control: You handle all billing and collections.
- ✅ Scalability: Your funding grows alongside your multi-location group.
- ✅ Certainty: A structured repayment schedule aligned with your actual cash flow.
Optimizing Accounts Receivable Performance
Pairing our financing with LEAN Six Sigma consulting can shorten your billing cycle, further reducing the need for long-term debt. We focus on improving both your professional and patient outcomes through white-glove services that provide the clarity you need to grow.
Unlock your practice's potential today. Contact White Coat Financial Partners at thewhitecoatadvantage.com or call 910-688-5077 for a confidential consultation.
About the Author
Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability. Connect with Stuart on LinkedIn.